Home/Interactome Biotherapeutics/Adam Koster

AK

Adam Koster

CEO, Co-Founder

Interactome Biotherapeutics

Therapeutic Areas

Neurology Oncology Cardiology Rare Disease

Interactome Biotherapeutics Pipeline

Drug	Indication	Phase
IB001	Nerve Injury	Pre-clinical

Leadership Team at Interactome Biotherapeutics

Frederick Naftolin, MD, PhD

Co-Founder, Vice President

James T. Secrest, MS, DC

Director, Research and Development

Ahvie Herskowitz, MD

Chief Medical Officer, Chair, Medical & Scientific Advisory Board

View full Interactome Biotherapeutics profile